603168 莎普爱思
已收盘 07-05 15:00:00
资讯
新帖
简况
莎普爱思06月21日主力资金流入193万元 连续3日加仓
自选股智能写手 · 06-21
莎普爱思06月21日主力资金流入193万元 连续3日加仓
眼科医疗概念盘中跳水,莎普爱思跌0.38%
自选股智能写手 · 06-19
眼科医疗概念盘中跳水,莎普爱思跌0.38%
眼科医疗概念盘中跳水,莎普爱思平盘
自选股智能写手 · 06-17
眼科医疗概念盘中跳水,莎普爱思平盘
莎普爱思上涨7.0%,报8.25元/股
金融界 · 06-14
莎普爱思上涨7.0%,报8.25元/股
莎普爱思上涨5.06% 主力净流入增加
智选洞察 · 06-14
莎普爱思上涨5.06% 主力净流入增加
莎普爱思:如有相关进展我们将及时按照上交所的相关规定进行披露
证券之星 · 06-13
莎普爱思:如有相关进展我们将及时按照上交所的相关规定进行披露
XD莎普爱(603168)6月13日主力资金净卖出592.03万元
证券之星 · 06-13
XD莎普爱(603168)6月13日主力资金净卖出592.03万元
莎普爱思董事长林弘立去年领薪78.8万元
金融界 · 06-11
莎普爱思董事长林弘立去年领薪78.8万元
莎普爱思创近4月新低 主力净流出98万元
智选洞察 · 06-11
莎普爱思创近4月新低 主力净流出98万元
莎普爱思上涨5.26% 主力净流入增加
智选洞察 · 06-06
莎普爱思上涨5.26% 主力净流入增加
莎普爱思(603168.SH)2023年度每股派0.021元 股权登记日为6月12日
智通财经 · 06-05
莎普爱思(603168.SH)2023年度每股派0.021元 股权登记日为6月12日
莎普爱思(603168.SH):公司硫酸阿托品滴眼液已进入III期临床试验
有连云 · 06-05
莎普爱思(603168.SH):公司硫酸阿托品滴眼液已进入III期临床试验
莎普爱思(603168.SH):目前正在积极推进盐酸毛果芸香碱滴眼液项目的研究开发
格隆汇资讯 · 06-04
莎普爱思(603168.SH):目前正在积极推进盐酸毛果芸香碱滴眼液项目的研究开发
莎普爱思创3月新低 主力净流出643万
智选洞察 · 06-03
莎普爱思创3月新低 主力净流出643万
莎普爱思(603168)5月29日主力资金净买入306.63万元
证券之星 · 05-29
莎普爱思(603168)5月29日主力资金净买入306.63万元
莎普爱思:业绩说明会定于6月3日举行
每日经济新闻 · 05-28
莎普爱思:业绩说明会定于6月3日举行
莎普爱思(603168)5月15日主力资金净卖出1684.32万元
证券之星 · 05-15
莎普爱思(603168)5月15日主力资金净卖出1684.32万元
莎普爱思创近1月新高 主力净流入543万元
智选洞察 · 05-13
莎普爱思创近1月新高 主力净流入543万元
AI制药新进展:谷歌推出新一代模型 产业链一览
腾讯自选股 · 05-09
AI制药新进展:谷歌推出新一代模型 产业链一览
莎普爱思最新公告:上海景兴拟减持不超1%股份
证券之星 · 05-07
莎普爱思最新公告:上海景兴拟减持不超1%股份
暂无数据
公司概况
公司名称:
浙江莎普爱思药业股份有限公司
所属行业:
医药制造业
上市日期:
2014-07-02
主营业务:
浙江莎普爱思药业股份有限公司主营业务为医药制造板块以及医疗服务板块。主要产品为苄达赖氨酸滴眼液、大输液、头孢克肟、诊疗服务。公司核心产品莎普爱思滴眼液属于眼科用药(抗白内障类)领域。公司利用营销网络优势,为莎普爱思滴眼液树立了良好的品牌和知名度,在国内白内障药物市场中处于行业前列。根据北京东方比特科技有限公司《中国白内障滴眼液市场研究报告》数据显示,2019年公司莎普爱思滴眼液在我国白内障用药市场份额为21.51%。
发行价格:
21.85
{"stockData":{"symbol":"603168","market":"SH","secType":"STK","nameCN":"莎普爱思","latestPrice":7.24,"timestamp":1720162800000,"preClose":7.03,"halted":0,"volume":5939892,"delay":0,"floatShares":323000000,"shares":379000000,"eps":0.019,"marketStatus":"已收盘","marketStatusCode":5,"change":0.21,"latestTime":"07-05 15:00:00","open":7.03,"high":7.25,"low":6.88,"amount":42143100,"amplitude":0.0526,"askPrice":7.25,"askSize":917,"bidPrice":7.24,"bidSize":535,"shortable":0,"etf":0,"ttmEps":0.019,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1720402200000},"adr":0,"adjPreClose":7.03,"symbolType":"stock","openAndCloseTimeList":[[1720143000000,1720150200000],[1720155600000,1720162800000]],"highLimit":7.73,"lowLimit":6.33,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":379161625,"pbRate":1.59,"roa":"--","roe":"0.25%","epsLYR":0.07,"committee":-0.04396,"marketValue":2745000000,"floatMarketCap":2336000000,"peRate":381.052644,"changeRate":0.0299,"turnoverRate":0.0184,"status":0},"requestUrl":"/m/hq/s/603168/tweets","defaultTab":"tweets","newsList":[{"id":"2445678728","title":"莎普爱思06月21日主力资金流入193万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2445678728","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445678728?lang=zh_cn&edition=full","pubTime":"2024-06-21 15:18","pubTimestamp":1718954324,"startTime":"0","endTime":"0","summary":"06月21日, 莎普爱思股价涨0.25%,报收7.96元,成交金额3218万元,换手率1.26%,振幅3.90%,量比0.98。莎普爱思今日主力资金净流入193万元,连续3日净流入,上一交易日主力净流入99万元,今日环比增加94.95%。该股近5个交易日下跌0.25%,主力资金累计净流入212万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出52万元,其中净流出天数为8日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406211531209f5591fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406211531209f5591fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2444490458","title":"眼科医疗概念盘中跳水,莎普爱思跌0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444490458","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444490458?lang=zh_cn&edition=full","pubTime":"2024-06-19 10:22","pubTimestamp":1718763744,"startTime":"0","endTime":"0","summary":"06月19日,眼科医疗概念盘中跳水,截至10点22分,眼科医疗概念整体指数下跌1.03%,报998.960点。从个股上来看,该概念的成分股中,莎普爱思跌0.38%,尖峰集团、ST目药、恒瑞医药跌幅居前。从资金上来看,截止发稿,眼科医疗概念主力净流入为-1.54亿,其中康恩贝受到资金热捧,主力净流入212.73万;拉长时间线来看,该板块近20日主力资金净流入-28.14亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619102224af8e290b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619102224af8e290b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2444218217","title":"眼科医疗概念盘中跳水,莎普爱思平盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2444218217","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444218217?lang=zh_cn&edition=full","pubTime":"2024-06-17 11:12","pubTimestamp":1718593927,"startTime":"0","endTime":"0","summary":"06月17日,眼科医疗概念盘中跳水,截至11点12分,眼科医疗概念整体指数下跌1.03%,报1010.200点。从个股上来看,该概念的成分股中,莎普爱思平盘,丰原药业跌幅居前。从资金上来看,截止发稿,眼科医疗概念主力净流入为-1.26亿,其中恒瑞医药受到资金热捧,主力净流入4487.18万;拉长时间线来看,该板块近20日主力资金净流入-22.35亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617111207968148d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617111207968148d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2443569032","title":"莎普爱思上涨7.0%,报8.25元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2443569032","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443569032?lang=zh_cn&edition=full","pubTime":"2024-06-14 13:08","pubTimestamp":1718341684,"startTime":"0","endTime":"0","summary":"6月14日,莎普爱思盘中上涨7.0%,截至13:08,报8.25元/股,成交1783.97万元,换手率0.71%,总市值31.28亿元。资料显示,浙江莎普爱思药业股份有限公司位于浙江省平湖市经济开发区新明路1588号,公司是一家专业从事药品研发、生产、经营的综合性制药企业,于2014年在上海证券交易所A股主板上市。截至3月31日,莎普爱思股东户数3.75万,人均流通股8608股。2024年1月-3月,莎普爱思实现营业收入1.38亿元,同比减少15.02%;归属净利润429.66万元,同比减少80.93%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061413131395af251c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061413131395af251c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2443690328","title":"莎普爱思上涨5.06% 主力净流入增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2443690328","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443690328?lang=zh_cn&edition=full","pubTime":"2024-06-14 13:07","pubTimestamp":1718341674,"startTime":"0","endTime":"0","summary":"06月14日,莎普爱思股价大幅上涨,截至13点07分,莎普爱思上涨5.06%,报8.10元/股,成交1730万元,换手率0.69%,振幅6.36%。资金动向截止发稿,莎普爱思获得主力净流入297万元,其中超大单流入153万元,大单流入144万元。主营业务及业绩莎普爱思公司主营业务为滴眼液、大输液和头孢克肟等产品的研发、生产和销售。最新财报显示,今年一季报,莎普爱思实现营业收入1.38亿元,同比减少15.02%,净利润为429.66万元,同比减少80.93%,基本每股收益为0.01元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614130803af8d8ae6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614130803af8d8ae6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2443509175","title":"莎普爱思:如有相关进展我们将及时按照上交所的相关规定进行披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2443509175","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443509175?lang=zh_cn&edition=full","pubTime":"2024-06-13 19:01","pubTimestamp":1718276505,"startTime":"0","endTime":"0","summary":"证券之星消息,莎普爱思06月13日在投资者关系平台上答复投资者关心的问题。相关信息请您关注后续公司披露的相关公告。如有相关进展我们将按照上交所的相关规定及时予以披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061319024795ac72c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061319024795ac72c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2443259520","title":"XD莎普爱(603168)6月13日主力资金净卖出592.03万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443259520","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443259520?lang=zh_cn&edition=full","pubTime":"2024-06-13 15:16","pubTimestamp":1718262980,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年6月13日收盘,XD莎普爱报收于7.71元,下跌2.28%,换手率1.17%,成交量3.79万手,成交额2947.5万元。6月13日的资金流向数据方面,主力资金净流出592.03万元,占总成交额20.09%,游资资金净流入11.3万元,占总成交额0.38%,散户资金净流入580.74万元,占总成交额19.7%。XD莎普爱主营业务:从事药品研发、生产、销售及医疗服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061300023287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2442334403","title":"莎普爱思董事长林弘立去年领薪78.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442334403","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442334403?lang=zh_cn&edition=full","pubTime":"2024-06-11 14:44","pubTimestamp":1718088274,"startTime":"0","endTime":"0","summary":"莎普爱思2023年年报数据显示,公司董事长林弘立2023年领取的薪酬为78.8万元。简历显示,林弘立先生:1993年出生,中国国籍,本科学历。现任上海养和实业有限公司、上海渝协医疗管理有限公司、上海谊和医疗管理有限公司等公司股东、法定代表人兼高管,浙江莎普爱思药业股份有限公司供应链与运营中心部门副总经理。莎普爱思年报数据还显示,2023年度,公司实现营业总收入6.45亿元,同比增长17.37%;实现归属于母公司股东的净利润为0.25亿元,同比减少43.23%。截至2023年底,公司员工总数为1385,当年员工人均薪酬为12.22万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406111445129f2fefc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406111445129f2fefc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2442802085","title":"莎普爱思创近4月新低 主力净流出98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442802085","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442802085?lang=zh_cn&edition=full","pubTime":"2024-06-11 09:41","pubTimestamp":1718070098,"startTime":"0","endTime":"0","summary":"06月11日,莎普爱思股价大幅下跌,截至09点41分,莎普爱思下跌5.01%,报7.59元/股,创近4月新低,成交1240万元,换手率0.49%,振幅4.51%。资金动向截止发稿,莎普爱思获得主力净流出98万元。主营业务及业绩莎普爱思公司主营业务为滴眼液、大输液和头孢克肟等产品的研发、生产和销售。最新财报显示,今年一季报,莎普爱思实现营业收入1.38亿元,同比减少15.02%,净利润为429.66万元,同比减少80.93%,基本每股收益为0.01元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611094157af8cd401&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611094157af8cd401&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2441758548","title":"莎普爱思上涨5.26% 主力净流入增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2441758548","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441758548?lang=zh_cn&edition=full","pubTime":"2024-06-06 10:41","pubTimestamp":1717641719,"startTime":"0","endTime":"0","summary":"06月06日,莎普爱思股价大幅上涨,截至10点41分,莎普爱思上涨5.26%,报8.01元/股,成交3833万元,换手率1.53%,振幅5.12%。资金动向截止发稿,莎普爱思获得主力净流入598万元,其中超大单流入401万元,大单流入197万元。主营业务及业绩莎普爱思公司主营业务为滴眼液、大输液和头孢克肟等产品的研发、生产和销售。最新财报显示,今年一季报,莎普爱思实现营业收入1.38亿元,同比减少15.02%,净利润为429.66万元,同比减少80.93%,基本每股收益为0.01元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606104308af8c4b71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606104308af8c4b71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2441524099","title":"莎普爱思(603168.SH)2023年度每股派0.021元 股权登记日为6月12日","url":"https://stock-news.laohu8.com/highlight/detail?id=2441524099","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441524099?lang=zh_cn&edition=full","pubTime":"2024-06-05 17:22","pubTimestamp":1717579377,"startTime":"0","endTime":"0","summary":"智通财经APP讯,莎普爱思(603168.SH)发布公告,公司将实施2023年年度权益分派,每股派发现金红利0.021元(含税),股权登记日为6月12日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1131418.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2441128982","title":"莎普爱思(603168.SH):公司硫酸阿托品滴眼液已进入III期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2441128982","media":"有连云","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441128982?lang=zh_cn&edition=full","pubTime":"2024-06-05 13:54","pubTimestamp":1717566857,"startTime":"0","endTime":"0","summary":"莎普爱思2024年6月4日发布消息称,2024年6月3日莎普爱思接受机构调研,董事长:林弘立;财务总监:林秀松;董事会秘书:黄明雄;独立董事:孙继伟参与接待,并回答了调研机构提出的问题。2024年一季度公司营收和归母净利润同比下降,主要系本期滴眼液、头孢等品类销售较去年同期下降所致。目前,公司正在积极推进硫酸阿托品滴眼液、盐酸毛果芸香碱滴眼液等项目的研究开发。其中,硫酸阿托品滴眼液已进入III期临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060513542495900142&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060513542495900142&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2440980406","title":"莎普爱思(603168.SH):目前正在积极推进盐酸毛果芸香碱滴眼液项目的研究开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2440980406","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440980406?lang=zh_cn&edition=full","pubTime":"2024-06-04 16:13","pubTimestamp":1717488794,"startTime":"0","endTime":"0","summary":"格隆汇6月4日丨莎普爱思(603168.SH)在公司2023年度暨2024年第一季度业绩说明会上表示,目前,公司正在积极推进盐酸毛果芸香碱滴眼液项目的研究开发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406041613259f181ec1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406041613259f181ec1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2440825104","title":"莎普爱思创3月新低 主力净流出643万","url":"https://stock-news.laohu8.com/highlight/detail?id=2440825104","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440825104?lang=zh_cn&edition=full","pubTime":"2024-06-03 10:46","pubTimestamp":1717382791,"startTime":"0","endTime":"0","summary":"06月03日,莎普爱思股价大幅下跌,截至10点46分,莎普爱思下跌5.09%,报7.83元/股,创近3月新低,成交3222万元,换手率1.25%。资金动向截止发稿,莎普爱思获得主力净流出643万元,其中超大单流出417万元,大单流出224万元。主营业务及业绩莎普爱思公司主营业务为滴眼液、大输液和头孢克肟等产品的研发、生产和销售。最新财报显示,今年一季报,莎普爱思实现营业收入1.38亿元,同比减少15.02%,净利润为429.66万元,同比减少80.93%,基本每股收益为0.01元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603104648aef2f002&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603104648aef2f002&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2439590299","title":"莎普爱思(603168)5月29日主力资金净买入306.63万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439590299","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439590299?lang=zh_cn&edition=full","pubTime":"2024-05-29 15:13","pubTimestamp":1716966795,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月29日收盘,莎普爱思报收于8.36元,上涨2.2%,换手率1.57%,成交量5.07万手,成交额4210.06万元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:莎普爱思2024年一季报显示,公司主营收入1.38亿元,同比下降15.02%;归母净利润429.66万元,同比下降80.93%;扣非净利润435.93万元,同比下降82.06%;负债率19.59%,投资收益17.2万元,财务费用48.24万元,毛利率51.33%。莎普爱思主营业务:从事药品研发、生产、销售及医疗服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052900024833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2438034617","title":"莎普爱思:业绩说明会定于6月3日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2438034617","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438034617?lang=zh_cn&edition=full","pubTime":"2024-05-28 15:52","pubTimestamp":1716882725,"startTime":"0","endTime":"0","summary":"莎普爱思(SH 603168,收盘价:8.18元)5月28日晚间发布公告称,公司2023年度暨2024年第一季度业绩说明会定于2024年6月3日(星期一)15:30-16:30,以网络互动的形式进行。出席本次业绩说明会的人员有:董事长、总经理林弘立先生,独立董事孙继伟先生,财务总监林秀松先生,董事会秘书黄明雄先生。2023年1至12月份,莎普爱思的营业收入构成为:医药工业占比72.74%,诊疗服务占比26.18%。截至发稿,莎普爱思市值为31亿元。文章来源:每日经济新闻原标题:莎普爱思:业绩说明会定于6月3日举行","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528155918956d7e45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528155918956d7e45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2435268889","title":"莎普爱思(603168)5月15日主力资金净卖出1684.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435268889","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435268889?lang=zh_cn&edition=full","pubTime":"2024-05-15 15:17","pubTimestamp":1715757453,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月15日收盘,莎普爱思报收于8.96元,下跌4.27%,换手率3.77%,成交量12.16万手,成交额1.1亿元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:莎普爱思2024年一季报显示,公司主营收入1.38亿元,同比下降15.02%;归母净利润429.66万元,同比下降80.93%;扣非净利润435.93万元,同比下降82.06%;负债率19.59%,投资收益17.2万元,财务费用48.24万元,毛利率51.33%。莎普爱思主营业务:从事药品研发、生产、销售及医疗服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500022064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2435239422","title":"莎普爱思创近1月新高 主力净流入543万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435239422","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435239422?lang=zh_cn&edition=full","pubTime":"2024-05-13 10:44","pubTimestamp":1715568242,"startTime":"0","endTime":"0","summary":"05月13日,莎普爱思股价大幅上涨,截至10点44分,莎普爱思上涨5.08%,报9.30元/股,创近1月新高,成交5055万元,换手率1.76%,振幅7.91%。资金动向截止发稿,莎普爱思获得主力净流入543万元,其中超大单流入470万元,大单流入73万元。最新财报显示,今年一季报,莎普爱思实现营业收入1.38亿元,同比减少15.02%,净利润为429.66万元,同比减少80.93%,基本每股收益为0.01元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131044117a597b7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131044117a597b7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2434611086","title":"AI制药新进展:谷歌推出新一代模型 产业链一览","url":"https://stock-news.laohu8.com/highlight/detail?id=2434611086","media":"腾讯自选股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434611086?lang=zh_cn&edition=full","pubTime":"2024-05-09 08:14","pubTimestamp":1715213647,"startTime":"0","endTime":"0","summary":"美东时间周三,谷歌DeepMind发布了新一代预测蛋白质结构的AlphaFold 3模型,能够帮助科学家更精确地针对疾病机制,从而开发出更有效的治疗药物。据太平洋证券医药,AI制药内涵丰富,主要包括:数字生物学、计算机药物发现、实验室自动化、AI 辅助临床试验等。整体而言AI技术在制药领域的应用价值主要体现在缩短试验周期、节省成本、促进新事物发现、提升试验成功概率等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509075702861ebda0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509075702861ebda0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688180","600196","600080","688363","BK0107","601728","603367","600220","600249","603229","600327","600252","600064","603806","603669","601360","688076","688111","603456","600682","600267","605116","603392","600056","600222","600161","BK0209","603676","688222","600812","603187","600420","688687","600351","600587","688278","600272","688331","688136","603520","BK0063","600332","688276","603127","603259","688073","600488","600211","600645","605177","600867","600227","600721","600276","600826","603168","600566","600613","600866","600789","688443","688062","BK0086","600521","603087","688289","600062","600535","601607","603567","688131","688202","688399","600381","688026","600624","600712","688520","603108","603566","688117"],"gpt_icon":0},{"id":"2433022827","title":"莎普爱思最新公告:上海景兴拟减持不超1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2433022827","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433022827?lang=zh_cn&edition=full","pubTime":"2024-05-07 16:21","pubTimestamp":1715070076,"startTime":"0","endTime":"0","summary":"莎普爱思公告,股东上海景兴拟减持不超过379万股公司股份,即不超过公司总股本的1%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050700026164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2014-07-02","address":"浙江省嘉兴市平湖市经济开发区新明路1588号","stockEarnings":[{"period":"1week","weight":-0.0385},{"period":"1month","weight":-0.0461},{"period":"3month","weight":-0.2652},{"period":"6month","weight":-0.401},{"period":"1year","weight":-0.1222},{"period":"ytd","weight":-0.4587}],"companyName":"浙江莎普爱思药业股份有限公司","boardCode":"AI0027","perCapita":"8608股","boardName":"医药制造业","registeredCapital":"37916万元","compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":-0.0377},{"period":"3month","weight":-0.0389},{"period":"6month","weight":0.0071},{"period":"1year","weight":-0.0798},{"period":"ytd","weight":-0.0084}],"survey":" 浙江莎普爱思药业股份有限公司主营业务为医药制造板块以及医疗服务板块。主要产品为苄达赖氨酸滴眼液、大输液、头孢克肟、诊疗服务。公司核心产品莎普爱思滴眼液属于眼科用药(抗白内障类)领域。公司利用营销网络优势,为莎普爱思滴眼液树立了良好的品牌和知名度,在国内白内障药物市场中处于行业前列。根据北京东方比特科技有限公司《中国白内障滴眼液市场研究报告》数据显示,2019年公司莎普爱思滴眼液在我国白内障用药市场份额为21.51%。","serverTime":1720387749171,"listedPrice":21.85,"stockholders":"37475人(较上一季度减少7.17%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莎普爱思(603168)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莎普爱思,603168,莎普爱思股票,莎普爱思股票老虎,莎普爱思股票老虎国际,莎普爱思行情,莎普爱思股票行情,莎普爱思股价,莎普爱思股市,莎普爱思股票价格,莎普爱思股票交易,莎普爱思股票购买,莎普爱思股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莎普爱思(603168)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}